This evidence has made cardiovascular history one of the strongest qualifying conditions for GLP-1 coverage
The holistic approach allows providers on the platform to combine customized medication management with ongoing clinical support, according to the company
In February 2026, full results from the REDEFINE 2 study showed CagriSema achieving 23% weight loss at 84 weeks but falling short of its primary endpoint under the treatment policy estimand (which measures efficacy across all patients regardless of whether they completed treatment, rather than only those who remained on it)
If you are on medication and are curious about berberine, talk to your doctor or pharmacist first, and do not stop or change anything you have been prescribed without medical advice
These findings suggest that GLP-1 RAs could play a crucial role in the management of HFpEF, particularly in patients with obesity, by targeting the underlying inflammatory processes and contributing to better overall cardiovascular outcomes
The Clinical Numbers How Big Is the Gap, Really
